Inhaled corticosteroid use and the incidence of lung cancer in COPD Source: Eur Respir J, 55 (2) 1901720; 10.1183/13993003.01720-2019 Year: 2020
Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study Source: Eur Respir J, 53 (6) 1801257; 10.1183/13993003.01257-2018 Year: 2019
Combination therapy of inhaled corticosteroids and long-acting beta2 -agonists may be associated with risk reduction of lung cancer in COPD patients who quit smoking Source: Eur Respir J 2006; 28: Suppl. 50, 454s Year: 2006
The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD Source: Eur Respir J, 54 (6) 1900521; 10.1183/13993003.00521-2019 Year: 2019
COPD and lung cancer incidence in never smokers Source: International Congress 2019 – Asthma and COPD comorbidities Year: 2019
Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis Source: Eur Respir J, 54 (1) 1900778; 10.1183/13993003.00778-2019 Year: 2019
Inhaled immunotherapy for lung cancer? Certainly possible. Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
COPD in patients with lung cancer and smoking Source: Eur Respir J 2005; 26: Suppl. 49, 519s Year: 2005
Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
COPD, asthma, and lung cancer patients Source: International Congress 2016 – ME13 Smoking cessation in difficult population groups Year: 2016
Lung disease induced by newer therapies for lung cancer: an update Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006
New and emerging targeted treatments in advanced lung cancer Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management Year: 2016
Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Management of concomitant COPD in patients with lung cancer Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
New and anticipated therapeutic developments in management of non-small-cell lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013
Emphysema, COPD and lung cancer screening. Update of an ongoing study Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Incidence of lung cancer among COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 494s Year: 2005
Common therapeutic approaches in IPF and lung cancer Source: Research Seminar 2015 Year: 2015
Risk factors for lung cancer in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017